New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …

The incidence of inflammatory bowel diseases (IBD) in East has risen over the past decade
to become a global disease. The increasing number of studies on the incidence and course …

Over 1 million residents in the USA and 2.5 million in Europe are estimated to have IBD, with
substantial costs for health care. These estimates do not factor in the'real'price of IBD, which …

Background & Aims A comprehensive knowledge of the natural history of ulcerative colitis
(UC) helps understand disease evolution, identify poor prognostic markers and impact of …

Background and aims. The inflammatory bowel diseases (IBD), Crohn's disease (CD) and
ulcerative colitis (UC), are chronic relapsing disorders of unknown aetiology. The aim of this …

Objective: Inflammatory bowel diseases (IBDs) are complex chronic inflammatory disorders
of the gastro-intestinal (GI) tract with uncertain etiology. IBDs comprise two idiopathic …

(1) Aims: To assess the incidence of inflammatory bowel disease (IBD) in Spain, to describe
the main epidemiological and clinical characteristics at diagnosis and the evolution of the …

Background Globally, the incidence rates of inflammatory bowel disease (IBD) are
increasing; however, data from high‐incidence areas are conflicting. Previous studies in …

Epidemiology, Natural History, and Risk Stratification of Crohn's Disease - Gastroenterology
Clinics Skip to Main Content Skip to Main Menu Advertisement Gastroenterology Clinics …

Most patients with ulcerative colitis (UC) have mild-to-moderate disease activity, with low risk
of colectomy, and are managed by primary care physicians or gastroenterologists. Optimal …